Table 1.
Patient anthropometrics, median of opioid consumption, and pain origin, in accordance to the diagnosis.
Variable | Methadone (n = 175) | Morphine (n = 87) | Total (n = 262) |
---|---|---|---|
Gender* n (%) | |||
Female | 116 (66.3%) | 49 (55.7%) | 165 (62.7%) |
Male | 59 (33.7%) | 38 (44.3%) | 98 (37.3%) |
Age† | 62.1 (±15.5) | 55.5 (±12.02) | 59.2 (±14.9) |
Opioid consumption‡ | 12.6 (±13.3) | 47.4 (±57.6) | — |
Cancer-related pain§ | 17 (9.7%) | 42 (48.2%) | 59 (22.5%) |
Pain origin‖ | |||
Nociceptive¶ | 53 (30.2%) | 51 (56.0%) | 104 (39.7%) |
Neuropathic# | 41 (23.4%) | 16 (18.3%) | 57 (21.7%) |
Mixed** | 61 (34.8%) | 17 (19%) | 78 (29.8%) |
Nociplastic†† | 19 (10.8%) | 2 (2.2%) | 21 (8%.0%) |
Missing data‡‡ | 1 (0.8%) | 1 (4.5%) | 2 (0%.8%) |
P = 0.106 (Fisher test).
Mean (standard deviation), P = 0.0002 (t test).
Mean during the entire follow-up period (standard deviation), value expressed in mg.
P < 0.0001 (Fisher test).
Mean; mixed pain = neuropathic and nociceptive components, P values (Fisher test).
P = <0.0001.
P = 0.42.
P = 0.014.
P = 0.015.
P = 1.